Skip NavigationSkip to Content

Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: Importance of the ligand-binding domain for intracellular GR trafficking

  1. Author:
    Kino, T.
    Stauber, R. H.
    Resau, J. H.
    Pavlakis, G. N.
    Chrousos, G. P.
  2. Author Address

    NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bldg 10, Room 9D42, 10 Ctr Dr, MSC 1583, Bethesda, MD 20892 USA. NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD 20892 USA. NCI, Human Retrovirus Sect, Ctr Canc Res, Frederick, MD 21702 USA. Kino T NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bldg 10, Room 9D42, 10 Ctr Dr, MSC 1583, Bethesda, MD 20892 USA.
    1. Year: 2001
  1. Journal: Journal of Clinical Endocrinology & Metabolism
    1. 86
    2. 11
    3. Pages: 5600-5608
  2. Type of Article: Article
  1. Abstract:

    The syndrome of familial or sporadic glucocorticoid resistance is characterized by hypercortisolism without the clinical stigmata of Cushing syndrome. This condition is usually caused by mutations of the human GR, a ligand-activated transcription factor that shuttles between the cytoplasm and the nucleus. A pathological human mutant receptor, in which Ile was replaced by Asn at position 559, had negligible ligand binding, was transcriptionally extremely weak, and exerted a transdominant negative effect on the transactivational activity of the wild- type GR, causing severe glucocorticoid resistance in the heterozygous state. To understand the mechanism of this mutant's trans-dominance, we constructed several N-terminal GR fusion chimeras to green fluorescent protein (GFP) and demonstrated that their transactivational activities were similar to those of the original proteins. The GFP-human (h) GR alpha I559N chimera was predominantly localized in the cytoplasm, and only high doses or prolonged glucocorticoid treatment triggered complete nuclear import that took 180 vs. 12 min for GFP-hGR alpha. Furthermore, hGR alpha I559N inhibited nuclear import of the wild-type GFP-hGR alpha, suggesting that its trans-dominant activity on the wild-type receptor is probably exerted at the process of nuclear translocation. As the ligand-binding domain (LBD) of the GR appears to play an important role in its nucleocytoplasmic shuttling, we also examined two additional GR-related fusion proteins. The natural hGRisoform beta (GFP-hGR beta), containing a unique LBD, was transactivation-inactive, moderately trans-dominant, and localized instantaneously and predominantly in the nucleus; glucocorticoid addition did not change its localization. Similarly, GFP-hGR514, lacking the entire LBD, was instantaneously and predominantly localized in the nucleus regardless of presence of glucocorticoids. Using a cell fusion system we demonstrated that nuclear export of GFP- hGR alpha I559N (250 min) and GFP-hGR beta (300 min) was drastically impaired compared with that of GFP-hGR alpha (50 min) and GFP-hGR514 (50 min), suggesting that an altered LBD may impede the exit of the GR from the nucleus. We conclude that the trans-dominant negative effect of the pathological mutant is exerted primarily at the translocation step, whereas that of the natural isoform beta is exerted at the level of transcription.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel